MedicalCV, Inc. to Present At RedChip Partners Investor Conference in New York - Sept. 19, 2002; Steve Forbes, Editor-in-Chief of Forbes Magazine, to Speak

Business Wire, Sept 9, 2002

Business Editors

MINNEAPOLIS--(BUSINESS WIRE)--Sept. 9, 2002

MedicalCV, Inc. (Nasdaq: MDCVU), a Minnesota-based heart valve company, will present at the RedChip Partners(TM) Investor Conference in New York on Thursday, Sept. 19, 2002. The presentation, which is scheduled for 4:00 p.m. ET, will include a brief review of the company's past performance and a major emphasis on its future growth prospects.

The conference, which will be held at Grand Hyatt New York, begins with on-site registration at 8 a.m. Corporate presentations are scheduled from 9 a.m. to 4:30 p.m. A schedule of corporate presentation times will be available on www.redchip.com before the conference. The hotel is located on Park Avenue at Grand Central Station.

The keynote speaker will be Steve Forbes, president and chief executive officer of Forbes and editor-in-chief of Forbes magazine. Mr. Forbes, a widely respected economic prognosticator, returned to publishing in 2000 after campaigning for the Republican nomination for the presidency and led the company's expansion into new publications and businesses. The company's flagship publication, Forbes, is the nation's leading business magazine, with a circulation of 850,000.

There is no charge for interested investors to attend the daylong event or to listen to a live webcast, but advance registration is required at www.redchip.com or by calling 1-800-REDCHIP (1-800-733-2447).

The conference will be webcast by CCBN and can be accessed at www.redchip.com beginning at 9 a.m. Eastern time on Sept. 19 and will be archived for 60 days on the site. Individual investors can also listen to company presentations through CCBN's individual investor center at www.companyboardroom.com. Institutional investors can access the conference via CCBN's password-protected event management site, StreetEvents (www.streetevents.com).

About MedicalCV, Inc.

MedicalCV, Inc. is a Minnesota-based heart valve manufacturer with a fully integrated manufacturing facility, where it designs, tests and manufactures all of its products. Based on its Omnicarbon(TM) heart valve's 18 years of excellent clinical results in Europe, Japan and Canada, the U.S. Food and Drug Administration gave premarket approval for the Omnicarbon valve in July 2001 for use in the United States, without requiring additional U.S. clinical trials. To date, more than 30,000 Omnicarbon valves have been implanted in patients in more than 30 countries. For more information on the company, visit its Web site at www.medcvinc.com or call 651-452-3000.

About RedChip(TM)

RedChip Companies, LLC is a well-established source of independent research and information on the small-cap market. Dedicated to "discovering tomorrow's blue chips today(TM)," its analysts seek out emerging growth companies and undiscovered small-cap values before they show up on Wall Street's radar screen. Through RedChip Review(TM), the company's flagship publication, analysts provide a unique breadth of coverage and depth of research on relatively unknown small-cap companies. RedChip Partners(TM) provides small-cap companies with access to professional and individual small-cap investors by holding conferences throughout the United States and producing online corporate visibility programs. RedChip Review(TM) was launched in 1993 by Marcus W. Robins, CFA. The company's research, publishing and corporate awareness businesses are based in Portland, Ore.